(177 days)
No
The device description and performance studies focus on biological and optical detection methods, with no mention of AI/ML algorithms for data analysis or interpretation.
No.
This device is a biological indicator used to monitor the effectiveness of steam sterilization processes for medical devices, not to treat or diagnose patients.
No
This device is a biological indicator used to monitor the effectiveness of steam sterilization processes, not to diagnose a medical condition in a patient.
No
The device is a biological indicator, which is a physical product containing biological material and media. It is used in conjunction with a hardware reader.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The device is intended for monitoring and testing steam sterilization processes. It assesses the effectiveness of a sterilization cycle, not to diagnose a disease or condition in a patient.
- Device Description: It uses a biological organism and nutrient media to indicate whether the sterilization process successfully killed the organism. This is a quality control measure for a sterilization process, not a diagnostic test performed on a biological sample from a patient.
- Anatomical Site and Patient Age Range: These are listed as "Not Applicable," which is consistent with a device used for process monitoring rather than patient diagnosis.
- Intended User / Care Setting: While used by healthcare providers, the context is within the sterilization process, not directly for patient diagnosis or treatment based on a biological sample.
IVDs are typically used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for the diagnosis, monitoring, or treatment of a disease or condition. This device does not perform such a function.
N/A
Intended Use / Indications for Use
The VERIFY Assert Self-Contained Biological Indicator (SCBI) is for routine monitoring, qualification testing and product testing of the following steam sterilization processes.
Cycle Type | Temperature | Time |
---|---|---|
Dynamic Air Removal | 270°F (132°C) | 4 minutes |
Dynamic Air Removal | 275°F (135°C) | 3 minutes |
Gravity | 250°F (121°C) | 30 minutes |
Gravity | 270°F (132°C) | 15 minutes |
When used in conjunction with the Reader for the VERIFY Assert Self-Contained Biological Indicator, the VERIFY Assert Self-Contained Indicator provides a fluorescent result within 40 minutes. |
Product codes
OWP
Device Description
The product is intended to monitor the critical parameters of steam sterilization cycles described in the indications for use by producing an optical change (signal) that is detected by the STERIS proprietary reader, Incubator for VERIFY Assert Self-Contained Biolgoical Indicator in 40 minutes to confirm the viability of the biological indicator at the end of a steam sterilization process. The product consists of a biological organism known to be resistant to steam (Geobacillus stearothermophilus) and a defined nutrient media. A reporter enzyme, which is produced by the organism, reacts with a fluorogenic substrate within the defined nutrient media to produce a fluorescent moiety.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Performance testing to demonstrate substantial equivalence to the predicate has been completed and is summarized in Table 5-2 below.
Test | Acceptance Criteria | Conclusion |
---|---|---|
Reduced Incubation Time (RIT) Testing | > 97% alignment of the 40-minute results with the conventional incubation time of 7 days | PASS |
Viable spore population | 1.0 - 4.0 x 10 spore/SCBI | 1.6 - 1.9 x 106 spore/SCBI |
Resistance | D121 ≥ 1.5 min D132 ≥ 10 s D135 ≥ 8 s | D121 ≥ 2.29 min D132 ≥ 49 s D135 ≥ 40 s |
Survival Time | Meets the longer of FDA and ISO 11138-3 requirements | 121 C ≥ 9.81 min 132 C ≥ 3.51 min 135 C ≥ 2.83 min |
Kill Time | Meets the shorter of FDA and ISO 11138-3 requirements | 121 C ≤ 25.57 min 132 C ≤ 9.21 min 135 C ≤ 7.73 min |
Carrier growth inhibition / media growth promotion | Positive growth of less than 100 spores after primary packaging and media are subject to worst case steam exposure | PASS |
Hold Time | Performance not affected if incubated within 72 hours of exposure to steam sterilization | PASS |
Simulated Use | Demonstrate growth when exposed to abbreviated cycle and all kill in a full cycle | Abbreviated cycle - growth Full cycle - no growth |
Process indicator | Meets requirements for a “Class 1” process indicator of ISO 11140-1:2005 | PASS Testing provided in K112256 |
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
N/A
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized graphic of three human profiles facing right, stacked on top of each other. The profiles are rendered in a dark color, possibly black or a dark shade of blue. The graphic is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 24, 2017
STERIS Corporation Mr. Anthony Piotrkowski Senior Manager, Regulatory Affairs 5960 Heisley Rd. Mentor, Ohio 44060
Re: K162701
Trade/Device Name: VERIFY Assert Self-Contained Biological Indicator Regulation Number: 21 CFR 880.2805 Regulation Name: Recombinant Biological Indicator Regulatory Class: Class II Product Code: OWP Dated: February 17, 2017 Received: February 21, 2017
Dear Mr. Anthony Piotrkowski:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
1
forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Michael J. Ryan -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K162701
Device Name
VERIFY Assert Self-Contained Biological Indicator
Indications for Use (Describe)
The VERIFY Assert Self-Contained Biological Indicator (SCBI) is for routine monitoring, qualification testing and product testing of the following steam sterilization processes.
Cycle Type | Temperature | Time |
---|---|---|
Dynamic Air Removal | 270°F (132°C) | 4 minutes |
Dynamic Air Removal | 275°F (135°C) | 3 minutes |
Gravity | 250°F (121°C) | 30 minutes |
Gravity | 270°F (132°C) | 15 minutes |
When used in conjunction with the Reader for the VERIFY Assert Self-Contained Biological Indicator, the VERIFY Assert Self-Contained Indicator provides a fluorescent result within 40 minutes.
Type of Use (Select one or both, as applicable) | |
---|---|
------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for STERIS. The word "STERIS" is written in a bold, serif font at the top of the image. Below the word, there is a graphic of several horizontal, wavy lines in blue. The lines are stacked on top of each other, creating a visual effect of water waves.
510(k) Summary For K162701 VERIFY Assert Self-Contained Biological Indicator
Sponsor Facility
STERIS Corporation 5960 Heisley Road Mentor, OH 44060 Phone: (440) 354-2600 Fax No: (440) 357-9198
Manufacturing Facility
STERIS Corporation 9325 Pinecone Drive Mentor, OH 44060 Phone: (440) 392-7800 Fax No: (440) 392-7896
Tony Piotrkowski Contact: Senior Manager, Regulatory Affairs
Telephone:(440) 392-7437 Fax No: (440) 357-9198 e-mail: tpiotrko@steris.com
Submission Date: March 15, 2017
Premarket Notification Number: K162701
STERIS Corporation ■ 5960 Heisley Road ■ Mentor, OH 44060-1834 USA ■ 440-354-2600
4
1. Device Name
Trade Name: | VERIFY Assert Self-Contained Biological Indicator |
---|---|
Common/usual Name: | Biological Indicator (BI, SCBI) |
Device Classification: | Class II |
Classification Name: | Recombinant Biological Indicator (21 CFR 880.2805, OWP) |
2. Predicate Device
VERIFY CRONOS Self-Contained Biological Indicator K102469/DEN110006
Reference Devices
3M Attest Super Rapid Readout Biological Indicator, Model 1492 K121484 Attest Rapid Readout Biological Indicator, Model 1292 K090569 Attest Rapid Readout Biological Indicator, Model 1291 K926364
3. Description_of Device
The product is intended to monitor the critical parameters of steam sterilization cycles described in the indications for use by producing an optical change (signal) that is detected by the STERIS proprietary reader, Incubator for VERIFY Assert Self-Contained Biolgoical Indicator in 40 minutes to confirm the viability of the biological indicator at the end of a steam sterilization process. The product consists of a biological organism known to be resistant to steam (Geobacillus stearothermophilus) and a defined nutrient media. A reporter enzyme, which is produced by the organism, reacts with a fluorogenic substrate within the defined nutrient media to produce a fluorescent moiety.
4. Intended Use/ Indications for Use
The VERIFY Assert Self-Contained Biological Indicator (SCBI) is for routine monitoring, qualification testing and product testing of the following steam sterilization processes.
Cycle Type | Temperature | Time |
---|---|---|
Dynamic Air Removal | 270°F (132°C) | 4 minutes |
Dynamic Air Removal | 275°F (135°C) | 3 minutes |
Gravity | 250°F (121°C) | 30 minutes |
Gravity | 270°F (132°C) | 15 minutes |
5
K162701/S001 STERIS Response to 11/23/16 Request for Additional Information VERIFY Assert Self-Contained Biological Indicator
When used in conjunction with the Reader for the VERIFY Assert Self-Contained Biological Indicator, the VERIFY Assert Self-Contained Indicator provides a fluorescent result within 40 minutes.
5. Summary of Technical Characteristics
A comparison of technical characteristics are summarized in Table 5-1.
Feature | Assert SCBI | VERIFY Cronos SCBI | |
---|---|---|---|
(proposed -K162701) | (predicate-K102469) | Comparison | |
Intended | |||
Use | The VERIFY Assert Self- | ||
Contained Biological | |||
Indicator (SCBI) is for | |||
routine monitoring, | |||
qualification testing and | |||
product testing of the | |||
following steam | |||
sterilization processes: | |||
270F, 4-minute dynamic | |||
air removal; 275F, 3- | |||
minute dynamic air | |||
removal; 250 F, 30 minute | |||
gravity; 270, 15-minutes | |||
gravity. | |||
When used in conjunction | |||
with the Reader for the | |||
VERIFY Assert Self- | |||
Contained Incubator, the | |||
VERIFY Assert Self- | |||
Contained Indicator | |||
provides a fluorescent | |||
result within 40 minutes. | For use by health care | ||
providers for qualification | |||
and routine monitoring of | |||
steam sterilization | |||
processes. The VERIFY | |||
Cronos SCBI is only | |||
validated to be used in the | |||
following steam | |||
sterilization cycles: | |||
132 C vacuum-assisted | |||
steam with 4-minute | |||
sterilization time; 135 C | |||
vacuum-assisted steam with | |||
3-minute sterilization time; | |||
121 C gravity steam with | |||
30-minute sterilization | |||
time; 132 C gravity steam | |||
with 15-minute | |||
sterilization time; 135 C | |||
gravity steam with 10- | |||
minute sterilization time; | |||
132 C Steam Flush Press | |||
ure Pulse with 4- minute | |||
sterilization time. | Both are intended for | ||
monitoring steam | |||
sterilization cycles. | |||
Use statement for the | |||
proposed device has been | |||
aligned with AAMI ST79, | |||
Table 6 recommendations | |||
for use of BI. | |||
The Assert SCBI is claiming | |||
different cycles compared to | |||
the predicate (no 10-minute | |||
135 gravity adding 135 | |||
SFPP). Simulated use | |||
testing in sterilizers with a | |||
load under pass and fail | |||
conditions demonstrate | |||
performance of the Assert | |||
SCBI in these additional | |||
cycles. | |||
Indicator | |||
organism | > 90% similarity to ATCC | ||
7953 Geobacillus | |||
stearothermophilus | > 90% similarity to ATCC | ||
7953 Geobacillus | |||
stearothermophilus | Same | ||
Mechanism | |||
of action | An enzyme, which is | ||
produced by the indicator | |||
organism, reacts with a | |||
fluorogenic substrate | |||
within the defined nutrient | |||
media to produce a | |||
fluorescent moiety | An enzyme, which is | ||
produced by the plasmid, | |||
reacts with a fluorogenic | |||
substrate within the defined | |||
nutrient media to produce a | |||
fluorescent moiety | Same mechanism of action, | ||
testing provided | |||
demonstrates conformance | |||
with ISO 11138 and the | |||
FDA guidance on BI | |||
submissions | |||
Accessories | Automated incubator / | ||
reader | Automated incubator / | ||
reader | RIT testing performed with | ||
the proposed | |||
incubator/reader. | |||
Viable spore | |||
population | 1.0 - 4.0 x 106 spore/SCBI | 1.0 - 5.0 x 106 spore/SCBI | Proposed population range |
within that of the predicate | |||
and both meet FDA | |||
guidance and ISO 11138 | |||
requirements | |||
Feature | Assert SCBI | ||
(proposed -K162701) | VERIFY Cronos SCBI | ||
(predicate-K102469) | Comparis on | ||
Resistance | $D_{121} ≥ 1.5$ min | ||
$D_{132} ≥ 10$ s | |||
$D_{135} ≥ 8$ s | 121°C - 1.5 to 3.0 min | ||
132°C - 10 to 30 sec | |||
134°C - 8 sec to 20 sec | |||
135°C - 8 sec to 20 sec | Both proposed and predicate | ||
meet criteria of ISO 11138-3 | |||
and FDA guidance | |||
Culture | |||
Conditions | 55- 59 °C, media included | ||
in SCBI, 40 minute | |||
incubation time. | 55- 59 °C, media included | ||
in SCBI, 120 minute | |||
incubation time. | RIT Testing and ISO 11138 | ||
media testing verifies | |||
performance | |||
Primary | |||
Packaging | Direct inoculum on plastic | ||
vial, cap with recovery | |||
media. | Inoculated paper in plastic | ||
vial with cap and glass | |||
ampoule with recovery | |||
media in capped vial. | Similar configuration. | ||
Component testing per ISO | |||
11138-1 Annex B | |||
demons trates packaging is | |||
compatible with indicator | |||
and sterilization process. | |||
Process | |||
indicator | STERIS STEAM Π | ||
(K112256) | STERIS STEAM Π | ||
(K112256) | Same indicator on both | ||
products |
Table 5-1 Summary of SCBI Physical Description and Technological Properties
6
K162701/S001 STERIS Response to 11/23/16 Request for Additional Information VERIFY Assert Self-Contained Biological Indicator
6. Summary of Nonclinical Tests
Performance testing to demonstrate substantial equivalence to the predicate has been completed and is summarized in Table 5-2 below.
Test | Acceptance Criteria | Conclusion |
---|---|---|
Reduced | ||
Incubation Time | ||
(RIT) Testing | Meets FDA's requirement of > 97% | |
alignment of the 40-minute results with the | ||
conventional incubation time of 7 days | PASS | |
Viable spore | ||
population | 1.0 - 4.0 x 10 spore/SCBI | 1.6 - 1.9 x 106 spore/SCBI |
Resistance | D121 ≥ 1.5 min | |
D132 ≥ 10 s | ||
D135 ≥ 8 s | D121 ≥ 2.29 min | |
D132 ≥ 49 s | ||
D135 ≥ 40 s | ||
Survival Time | Meets the longer of FDA and ISO 11138-3 | |
requirements | 121 C ≥ 9.81 min | |
132 C ≥ 3.51 min | ||
135 C ≥ 2.83 min | ||
Kill Time | Meets the shorter of FDA and ISO 11138-3 | |
requirements | 121 C ≤ 25.57 min | |
132 C ≤ 9.21 min | ||
135 C ≤ 7.73 min | ||
Carrier growth | ||
inhibition / media | ||
growth promotion | Positive growth of less than 100 spores after | |
primary packaging and media are subject to | ||
worst case steam exposure | PASS | |
Hold Time | Performance not affected if incubated | |
within 72 hours of exposure to steam | ||
sterilization | PASS | |
Simulated Use | Demonstrate growth when exposed to | |
abbreviated cycle and all kill in a full cycle | Abbreviated cycle - | |
growth | ||
Full cycle - no growth |
Table 5-2. Summary of Non-clinical Testing
7
K162701/S001 STERIS Response to 11/23/16 Request for Additional Information VERIFY Assert Self-Contained Biological Indicator
Test | Acceptance Criteria | Conclusion |
---|---|---|
Process indicator | Meets requirements for a “Class 1” process | |
indicator of ISO 11140-1:2005 | PASS | |
Testing provided in | ||
K112256 |
7. Conclusion
The VERIFY Assert Self-Contained Biological Indicator has met the established performance criteria. The results of the studies demonstrate that the biological indicator performs as intended, and based on the nonclinical tests performed, the subject device is substantially equivalent and is as safe and as effective as the legally marketed predicate device Class II (21 CFR 880.2805, Product code OWP).